Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis Factors and Outcomes of Neuro-ophthalmologic Sarcoidosis.
Leclercq M, Sené T, Chapelon-Abric C, Desbois AC, Domont F, Maillart E, Shor N, Vignal-Clermont C, Guéguen A, Bodaghi B, Cacoub P, Touitou V, Saadoun D. Leclercq M, et al. Ocul Immunol Inflamm. 2022 May 19;30(4):821-828. doi: 10.1080/09273948.2020.1834585. Epub 2020 Nov 9. Ocul Immunol Inflamm. 2022. PMID: 33166196
Biotherapies in Uveitis.
Leclercq M, Desbois AC, Domont F, Maalouf G, Touhami S, Cacoub P, Bodaghi B, Saadoun D. Leclercq M, et al. J Clin Med. 2020 Nov 8;9(11):3599. doi: 10.3390/jcm9113599. J Clin Med. 2020. PMID: 33171664 Free PMC article. Review.
Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'.
Comarmond C, Leclercq M, Leroux G, Marques C, Le Joncour A, Domont F, Hatte C, Toquet-Bouedec S, Guillaume-Jugnot P, Desbois AC, Vautier M, Rigolet A, Allenbach Y, Benveniste O, Saadoun D, Cacoub P. Comarmond C, et al. Among authors: leclercq m. Ann Rheum Dis. 2023 Feb;82(2):e30. doi: 10.1136/annrheumdis-2020-219407. Epub 2020 Nov 12. Ann Rheum Dis. 2023. PMID: 33184046 No abstract available.
Differential Diagnosis of Vitritis in Adult Patients.
Touhami S, Leclercq M, Stanescu-Segall D, Touitou V, Bodaghi B. Touhami S, et al. Among authors: leclercq m. Ocul Immunol Inflamm. 2021 May 19;29(4):786-795. doi: 10.1080/09273948.2021.1898001. Epub 2021 May 18. Ocul Immunol Inflamm. 2021. PMID: 34003716 Review.
Perspectives for immunotherapy in noninfectious immune mediated uveitis.
Touhami S, Gueudry J, Leclercq M, Touitou V, Ghembaza A, Errera MH, Saadoun D, Bodaghi B. Touhami S, et al. Among authors: leclercq m. Expert Rev Clin Immunol. 2021 Sep;17(9):977-989. doi: 10.1080/1744666X.2021.1956313. Epub 2021 Jul 26. Expert Rev Clin Immunol. 2021. PMID: 34264142 Review.
Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis.
Desbois AC, Marques C, Lefèvre L, Barmo S, Lorenzo C, Leclercq M, Leroux G, Comarmond C, Chapelon-Abric C, Domont F, Vautier M, Saadoun D, Cacoub P. Desbois AC, et al. Among authors: leclercq m. Clin Exp Rheumatol. 2022 Jan;40(1):195-196. doi: 10.55563/clinexprheumatol/b7zd6b. Epub 2021 Aug 5. Clin Exp Rheumatol. 2022. PMID: 34369358 Free article. No abstract available.
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.
Leclercq M, Andrillon A, Maalouf G, Sève P, Bielefeld P, Gueudry J, Sené T, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, El Chamieh C, Cacoub P, Bodaghi B, Biard L, Saadoun D. Leclercq M, et al. Ophthalmology. 2022 May;129(5):520-529. doi: 10.1016/j.ophtha.2021.11.013. Epub 2021 Nov 16. Ophthalmology. 2022. PMID: 34793830 Free article.
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients.
Maalouf G, Andrillon A, Leclercq M, Sève P, Bielefeld P, Gueudry J, Sené T, Titah C, Moulinet T, Rouvière B, Sène D, Desbois AC, Domont F, Touhami S, Thibault T, Chamieh CE, Cacoub P, Kodjikian L, Biard L, Bodaghi B, Saadoun D. Maalouf G, et al. Among authors: leclercq m. Am J Ophthalmol. 2022 Jun;238:173-180. doi: 10.1016/j.ajo.2022.02.002. Epub 2022 Feb 13. Am J Ophthalmol. 2022. PMID: 35172172
Reply.
Leclercq M, Saadoun D. Leclercq M, et al. Ophthalmology. 2022 Jul;129(7):e77-e78. doi: 10.1016/j.ophtha.2022.02.020. Epub 2022 Mar 25. Ophthalmology. 2022. PMID: 35346509 No abstract available.
293 results